28 October 2019 15:15 - 15:45
Mass spectrometry achieving prominence in clinical medicine
Dobrin A Svinarov
Professor Dr. Med. Dr h.c. Dobrin Svinarov is a specialist of clinical laboratory medicine and clinical pharmacology, Head of Clinical Laboratory and Clinical Pharmacology at Alexandrovska University Hospital, Chairman of the Department of Clinical Laboratory and Clinical Immunology at the Faculty of Medicine, Medical University of Sofia, and President of the Bulgarian Society of Clinical laboratory. He is academician of the Bulgarian Academy of Sciences and Arts, and President of its General Assembly. Professor Svinarov has more than 30 years of experience in the measurement of drugs as a guide to therapy, and has been responsible for the development of wide range of chromatographic and LC-MS/MS assays to monitor variety of therapeutic agents. In 1987 he specialized therapeutic drug monitoring at National Institutes of Health, Bethesda MD, and at Cleveland Clinic Foundation, Cleveland OH, USA. In 1990 he became one of the co-founders of IATDMCT, and in 1997-1999, served as Councilor of the Executive Board of the Association. In 1999-2000 professor Svinarov was granted a one year Stecker Scholar Stipend and performed the duties of visiting professor of pediatric clinical pharmacology at Columbus Childrens’ Hospital, Ohio State University, OH, USA. After his return in Bulgaria he was involved in definitive clinical trials and pharmacokinetic studies of a broad range of new drugs and established the first General Clinical Research Center for the Medical University of Sofia. Since 1997 now professor Svinarov serves as National Referee and Consultant for Clinical Laboratory Medicine at the Ministry of Health. His research interests are in the field of laboratory medicine, therapeutic drug monitoring and clinical pharmacology, and include the development of mass-spectrometric assays for the measurement of therapeutic drugs and endogenous markers of organ damage and dysfunction, proteomic research, pharmacodynamic biomarkers, and personalized medicine. Professor Svinarov and his colleagues received continuous funding from sponsors such as the National Research Foundation of the Bulgarian Ministry of Education & Science, Medical University of Sofia, Volkswagen Foundation, and Industry. He and his collaborators authored over 350 scientific works, including books and book chapters, publications in peer reviewed journals and invited lectures all over the world. He is an active member of several national and international scientific societies, and serves as reviewer and Editorial Board member of several peer reviewed journals, including Therapeutic Drug Monitoring. Professor Svinarov performed the duties of Bureau member of WASPaLM for the period 2013-2017 year.
Papillon Zeugma Convention Centre, Belek Antalya - TURKEY
October 27-31, 2019